{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-121727","form_type":"8-K","ticker":null,"cik":"0000861838","company_name":"Aceragen, Inc.","filed_at":"2022-11-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.775526+00:00","generated_at":"2026-06-21T13:43:35.364553+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Idera Pharmaceuticals receives Nasdaq delisting notice over bid price non-compliance","bullets":["Notified by Nasdaq Staff of delisting due to continued non-compliance with minimum $1.00 bid price.","Company plans to timely request a hearing before Nasdaq Hearings Panel to stay delisting.","Previous grace periods expired on November 21, 2022; no further automatic compliance period.","Panel may grant extension up to 180 days, through May 22, 2023, at its discretion."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-121727","json":"https://secwatch.observer/filing/0001104659-22-121727.json","markdown":"https://secwatch.observer/filing/0001104659-22-121727.md","text":"https://secwatch.observer/filing/0001104659-22-121727.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/861838/000110465922121727/0001104659-22-121727-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/861838/000110465922121727/tm2231244d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T13:43:35.364553+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"01648677041f1699d2ff93876e17d5a74ce22560","claim":"Aceragen, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"November 22, 2022, Idera Pharmaceuticals, Inc. (the “Company”) was notified by the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the Company’s continued non-compliance with Nasdaq Listing Rule 5550(a)(2), which requires maintenance of a minimum closing bid price of $1.00 per share (the “Bid Price Requirement”), the Company’s securities were subject to delisting unless the Company timely requested a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company plans to timely request a hearing before the Panel, which request wil","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/861838/000110465922121727/0001104659-22-121727-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}